.svg)
In 2017, Bronwyn created ANDHealth to address an identified gap in the Australian Innovation landscape: to provide support to digital health companies specific to the challenges of commercialising in this emerging sector. The unique, non-profit, industry-led model devised by Bronwyn helps Australian digital health companies to navigate the pathway to institutional investment and international market entry. To date, ANDHealth has demonstrated unprecedented impact, impacting the lives of more than 770,000 patients and catalysing over $90M of new investment into SMEs in the sector.
Bronwyn has secured more than $33M of private and public funding to provide unprecedented support for Australia’s nascent digital health sector to 2026. This includes securing $19.75M from the highly competitive Australian Government’s MRFF Early Stage Translation and Commercialisation Support Initiative, the largest single investment into digital health commercialisation by any Australian government — a significant boost to building a globally competitive Australian digital health industry, underpinning better health outcomes and significant export opportunities.
“The impact of what Bronwyn has built cannot be underestimated,” said Kate Quirke, ANDHealth Non-Executive Director and Group Managing Director of Alcidion. “Bronwyn was one of the first to recognize that evidence-based digital health and digital medicine technologies offer Australia enormous health and economic opportunities, leveraging our international strengths in health and medical research with our emerging capabilities in technology.”
Bronwyn actively advocates for the digital health sector nationally and internationally through numerous speaking and panellist engagements and membership of advisory boards. She is highly collaborative, seeking to work alongside others rather than to expend scarce resources in unnecessary competition, and is a valued partner in Australia’s digital health ecosystem.
.svg)
.svg)
